These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23723590)

  • 1. Bone scintigraphy in osseous sarcoidosis.
    Cengiz A; Saki H; Yürekli Y
    Indian J Nucl Med; 2012 Apr; 27(2):130-2. PubMed ID: 23723590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
    Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
    Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional imaging in extrapulmonary sarcoidosis: FDG-PET/CT and MR features.
    Soussan M; Augier A; Brillet PY; Weinmann P; Valeyre D
    Clin Nucl Med; 2014 Feb; 39(2):e146-59. PubMed ID: 23579973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 18F-FDG and 67Ga-citrate in sarcoidosis imaging.
    Prager E; Wehrschuetz M; Bisail B; Woltsche M; Schwarz T; Lanz H; Sorantin E; Aigner RM
    Nuklearmedizin; 2008; 47(1):18-23. PubMed ID: 18278208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. F-18 FDG PET/CT for detecting bone and bone marrow involvement in sarcoidosis patients.
    Mostard RL; Prompers L; Weijers RE; van Kroonenburgh MJ; Wijnen PA; Geusens PP; Drent M
    Clin Nucl Med; 2012 Jan; 37(1):21-5. PubMed ID: 22157023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, distribution and clinical significance of joints, muscles and bones in sarcoidosis: an
    Papiris SA; Manali ED; Papaioannou AI; Georgakopoulos A; Kolilekas L; Pianou NK; Kallergi M; Papaporfyriou A; Kallieri M; Apollonatou V; Papadaki G; Malagari K; Kelekis NL; Pneumatikos SG; Chatziioannou S
    Expert Rev Respir Med; 2020 Sep; 14(9):957-964. PubMed ID: 32460642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osseous sarcoidosis: a case series.
    Kuzyshyn H; Feinstein D; Kolasinski SL; Eid H
    Rheumatol Int; 2015 May; 35(5):925-33. PubMed ID: 25362525
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Demaria L; Borie R; Benali K; Piekarski E; Goossens J; Palazzo E; Forien M; Dieudé P; Crestani B; Ottaviani S
    Clin Rheumatol; 2020 Sep; 39(9):2727-2734. PubMed ID: 32198555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osseous sarcoidosis: clinical characteristics, treatment, and outcomes--experience from a large, academic hospital.
    Sparks JA; McSparron JI; Shah N; Aliabadi P; Paulson V; Fanta CH; Coblyn JS
    Semin Arthritis Rheum; 2014 Dec; 44(3):371-9. PubMed ID: 25129260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscular sarcoidosis: Ga-67 scintigraphy and magnetic resonance imaging.
    Sohn HS; Kim EN; Park JM; Chung YA
    Clin Nucl Med; 2001 Jan; 26(1):29-32. PubMed ID: 11139049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcoidosis: radiographic manifestations in the nails and distal phalanges.
    Albers BK; Sluzevich JC; Garner HW
    Skeletal Radiol; 2016 May; 45(5):717-21. PubMed ID: 26768259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osseous sarcoidosis presenting as a destructive petrous apex lesion.
    Ng M; Niparko JK
    Am J Otolaryngol; 2002; 23(4):241-5. PubMed ID: 12105791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis.
    Ishimaru S; Tsujino I; Takei T; Tsukamoto E; Sakaue S; Kamigaki M; Ito N; Ohira H; Ikeda D; Tamaki N; Nishimura M
    Eur Heart J; 2005 Aug; 26(15):1538-43. PubMed ID: 15809286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis.
    Nishiyama Y; Yamamoto Y; Fukunaga K; Takinami H; Iwado Y; Satoh K; Ohkawa M
    J Nucl Med; 2006 Oct; 47(10):1571-6. PubMed ID: 17015889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ¹⁸F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis.
    Ohira H; Tsujino I; Yoshinaga K
    Eur J Nucl Med Mol Imaging; 2011 Sep; 38(9):1773-83. PubMed ID: 21559980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osseous manifestations of sarcoidosis.
    Kucharz EJ
    Reumatologia; 2020; 58(2):93-100. PubMed ID: 32476682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis.
    Okumura W; Iwasaki T; Toyama T; Iso T; Arai M; Oriuchi N; Endo K; Yokoyama T; Suzuki T; Kurabayashi M
    J Nucl Med; 2004 Dec; 45(12):1989-98. PubMed ID: 15585472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of 18F-fluoro-2-deoxyglucose positron emission tomography and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
    Shen YY; Kao A; Yen RF
    Oncol Rep; 2002; 9(2):321-5. PubMed ID: 11836600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unusual cause of generalized osteolytic vertebral lesions: a case report.
    Nanda S; Bhatt SP; Steinberg D; Volk SA
    J Med Case Rep; 2007 Jun; 1():33. PubMed ID: 17594503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.